BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index
 

Biotech 100 Requirements
Google
Web www.biotech100.com

 

 

 

The Biotech-100 Index includes 100 small cap biotechnology stocks whose product pipeline contain at least one drug in either phase II and/or Phase III clinical development.

There is a 90% chance of rejection in early-stage phase I trials;

a 50% chance in phase II;

20% in phase III;

and 10% post-phase III are rough guidelines.

Companies that are in phase II and III tend to show great promise but still have a high degree of volatiliy.

See the Biotech100 List

 

 


Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?
Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?
Key Biotech Terms

 

   
 
 

 

 


Copyright 2005 Biotech100.com. All rights reserved